US FDA Approves Janssen’s IMBRUVICA to Treat Chronic Graft-Versus-Host Disease

The US Food and Drug Administration (FDA) of the United States has approved Janssen Pharmaceutical’s IMBRUVICA for the treatment of pediatric patients one year and older suffering with chronic graft-versus-host disease after the failure of more than one therapy. Janssen claims that, this milestone marks the first pediatric indication for IMBRUVICA, and the launch of […]

Continue Reading

GE Healthcare and AWS Announced first European Cloud Deployment in UK

GE Healthcare and Amazon Web Services (AWS) announced the first European cloud deployment of Edison True PACS at the Royal Orthopaedic Hospital NHS Foundation Trust in Birmingham, the United Kingdom. This project is aiming to provide radiologists with intelligent productivity tools that provide help in enhancing reading speed, and reducing errors, with improve diagnostic precision, […]

Continue Reading

British Veterinary Association Issues Warning After Dog-to-Human Cases of Serious Disease

The British Veterinary Association have issued an urgent warning about the severe health risks of importing the dogs from abroad into the United Kingdom. It follows a woman being hospitalized after the first dog-to-human case of the disease called as Brucella canis in the United Kingdom. The British Veterinary Association is also repeating its calls […]

Continue Reading